A detailed history of N Verses Capital, LLC transactions in Innoviva, Inc. stock. As of the latest transaction made, N Verses Capital, LLC holds 3,800 shares of INVA stock, worth $73,758. This represents 0.04% of its overall portfolio holdings.

Number of Shares
3,800
Previous 5,700 33.33%
Holding current value
$73,758
Previous $86.9 Million 28.26%
% of portfolio
0.04%
Previous 0.21%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$14.4 - $16.4 $27,360 - $31,159
-1,900 Reduced 33.33%
3,800 $62.3 Million
Q1 2024

Apr 25, 2024

BUY
$14.56 - $16.78 $82,992 - $95,646
5,700 New
5,700 $86.9 Million

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.35B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track N Verses Capital, LLC Portfolio

Follow N Verses Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of N Verses Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on N Verses Capital, LLC with notifications on news.